During the past decade, West Tennessee Research Institute conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 33 clinical trials were completed, i.e. on average, 89.2% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 16 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "West Tennessee Research Institute" #1 sponsor was "Pfizer" with 13 trials, followed by "Bristol-Myers Squibb" with 10 trials sponsored, "Amgen" with 5 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "West Tennessee Research Institute" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator, "Oregon Health and Science University" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "West Tennessee Research Institute" are "Rheumatoid Arthritis" (21 trials), "Psoriatic Arthritis" (7 trials), "Arthritis, Rheumatoid" (6 trials), "Systemic Lupus Erythematosus" (4 trials) and "Lupus Erythematosus, Systemic" (3 trials). Many other conditions were trialed in "West Tennessee Research Institute" in a lesser frequency.

Most popular intervention types in "West Tennessee Research Institute" are "Drug" (46 trials), "Biological" (11 trials), "Other" (11 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Methotrexate" (7 trials), "Abatacept" (5 trials), "Adalimumab" (3 trials) and "Baricitinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "West Tennessee Research Institute" are 52 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "West Tennessee Research Institute". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in West Tennessee Research Institute, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in West Tennessee Research Institute, 2 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 1 trials that are defined as “Not Applicable".